Ftse Mib
34.245,26
-0,38%
DAX
18.482,07
-0,63%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,00%
Bitcoin
63.811,09
-1,60%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

EVG

Evgen Pharma (EVG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
04/10/201708:00UK RegulatoryEvgen Pharma PLC First European Patent GrantLSE:EVGEvgen Pharma Plc
31/08/201708:01UK RegulatoryEvgen Pharma PLC Issue of Equity and Total Voting RightsLSE:EVGEvgen Pharma Plc
02/08/201714:00RNS Non-RegulatoryEvgen Pharma PLC SFX-01 data published in Peer Reviewed JournalLSE:EVGEvgen Pharma Plc
27/07/201708:03UK RegulatoryEvgen Pharma PLC Result of AGMLSE:EVGEvgen Pharma Plc
26/07/201713:42Alliance NewsAlliance NewsEvgen Pharma Progressing With Clinical Trials For Sulforaphane DrugLSE:EVGEvgen Pharma Plc
26/07/201708:00UK RegulatoryEvgen Pharma PLC AGM StatementLSE:EVGEvgen Pharma Plc
11/07/201714:02Alliance NewsAlliance NewsEvgen Drug Test Against Breast Cancer To Be Funded By DonationLSE:EVGEvgen Pharma Plc
11/07/201713:30UK RegulatoryEvgen Pharma PLC Charity-funded Study of SFX-01 in TNBCLSE:EVGEvgen Pharma Plc
21/06/201711:00UK RegulatoryEvgen Pharma PLC Posting of Annual Report and AGM NoticeLSE:EVGEvgen Pharma Plc
21/06/201708:15RNS Non-RegulatoryEvgen Pharma PLC Hardman Research: Making clinical progressLSE:EVGEvgen Pharma Plc
13/06/201714:27Alliance NewsAlliance NewsEvgen Pharma Loss Widens As SFX-01 Clinical Trials ProgressLSE:EVGEvgen Pharma Plc
13/06/201708:00UK RegulatoryEvgen Pharma PLC Full Year ResultsLSE:EVGEvgen Pharma Plc
01/06/201710:55Alliance NewsAlliance NewsEvgen Pharma SFX-01 Trials Progressing With No Safety Issues To DateLSE:EVGEvgen Pharma Plc
01/06/201708:00UK RegulatoryEvgen Pharma PLC Compassionate Use Programme and Trials UpdateLSE:EVGEvgen Pharma Plc
25/05/201708:02UK RegulatoryEvgen Pharma PLC Notice of Preliminary ResultsLSE:EVGEvgen Pharma Plc
03/04/201715:15UK RegulatoryEvgen Pharma PLC Directorate ChangeLSE:EVGEvgen Pharma Plc
28/03/201716:02Alliance NewsAlliance NewsEvgen Pharma Granted US Patent Covering Lead Product SFX-01LSE:EVGEvgen Pharma Plc
28/03/201715:45UK RegulatoryEvgen Pharma PLC Further US Patent GrantLSE:EVGEvgen Pharma Plc
06/03/201708:00UK RegulatoryEvgen Pharma PLC Issue of Equity, PDMR Shareholding and TVRLSE:EVGEvgen Pharma Plc
14/02/201714:34Alliance NewsAlliance NewsEvgen Pharma Gets US Patent Covering Lead Product SFX-01LSE:EVGEvgen Pharma Plc
14/02/201714:30UK RegulatoryEvgen Pharma PLC Patent Grant in the United StatesLSE:EVGEvgen Pharma Plc
13/02/201709:06Alliance NewsAlliance NewsEvgen Pharma Signs Services Deal For SFX-01 Drug With APTransLSE:EVGEvgen Pharma Plc
13/02/201708:00RNS Non-RegulatoryEvgen Pharma PLC Services Agreement with APTransLSE:EVGEvgen Pharma Plc
17/01/201710:23Alliance NewsAlliance NewsEvgen Pharma Doses First Breast Cancer Trial Patients; Hires New CFOLSE:EVGEvgen Pharma Plc
17/01/201708:00UK RegulatoryEvgen Pharma PLC Appointment of CFO and Head of Clinical OperationsLSE:EVGEvgen Pharma Plc
17/01/201708:00UK RegulatoryEvgen Pharma PLC First Patient Dosed in Breast Cancer TrialLSE:EVGEvgen Pharma Plc
11/01/201710:17Alliance NewsAlliance NewsEvgen Pharma Gets Positive Review For SFX-01 Phase II StudyLSE:EVGEvgen Pharma Plc
11/01/201708:00UK RegulatoryEvgen Pharma PLC Positive DSMB Review of SAS TrialLSE:EVGEvgen Pharma Plc
05/12/201611:01Alliance NewsAlliance NewsEvgen Pharma Eyeing Third Clinical Programme After First Half ProgressLSE:EVGEvgen Pharma Plc
05/12/201608:46UK RegulatoryEvgen Pharma PLC Half Yearly ReportLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

NASDAQ
SABR
Sabre
LSE
SPED
Ivz Sp Eqw D
NASDAQ
KVHI
KVH Industries
LSE
IVPH
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network